SCHEMBL17876310

SCHEMBL17876310

c1ccc(N2Cc3ccc(-c4cc(-c5cccnc5)cc(-c5cccnc5)c4)cc3-c3cc(-c4cc(-c5cccnc5)cc(-c5cccnc5)c4)ccc3C2)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 10/20 0.48
CYP11B1 P15538 9/20 0.48
TDP2 O95551 2/20 0.46
CYP19A1 P11511 4/20 0.44
CYP17A1 P05093 2/20 0.44
CYP1A2 P05177 4/20 0.44
CYP3A4 P08684 3/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
PIM1 P11309 1/20 0.41
PIM3 Q86V86 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP2A6 P11509 1/20 0.41
GLO1 Q04760 1/20 0.40
MAP3K5 Q99683 1/20 0.40
KDM1A O60341 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876313 0.99 TDP2 (0.48) CYP11B2CYP11B1TDP2CYP19A1CYP17A1
SCHEMBL17876273 0.95 CYP11B1 (0.47) CYP11B2CYP11B1TDP2CYP19A1CYP17A1
SCHEMBL17876263 0.94 TDP2 (0.47) CYP11B2CYP11B1TDP2CYP19A1CYP17A1
SCHEMBL17876270 0.94 TDP2 (0.47) CYP11B2CYP11B1TDP2CYP19A1CYP17A1
SCHEMBL17876315 0.93 CYP19A1 (0.51) CYP11B2CYP11B1TDP2CYP19A1CYP17A1
SCHEMBL17876283 0.89 CYP19A1 (0.47) CYP11B2CYP11B1TDP2CYP19A1CYP17A1
SCHEMBL17876272 0.89 CYP19A1 (0.47) CYP11B2CYP11B1TDP2CYP19A1CYP17A1
SCHEMBL17876288 0.88 PIM1 (0.39) CYP11B2CYP11B1TDP2CYP19A1CYP17A1
SCHEMBL17876298 0.87 CYP11B1 (0.38) CYP11B2CYP11B1TDP2CYP19A1CYP17A1
SCHEMBL17876304 0.87 PIM1 (0.38) CYP11B2CYP11B1TDP2CYP19A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 CYP11B2 1374/4885CYP11B1 938/4885TDP2 3979/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP11B2 1374/4885CYP11B1 938/4885TDP2 3979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.